6084 Efficacy and safety of bevacizumab-based combination regimens in patients with metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab + FOLFIRI vs. bevacizumab + XELIRI (FNCLCC ACCORD 13/0503 study)

✍ Scribed by Ducreux, M.; Adenis, A.; Pignon, J.P.; François, E.; Chauffert, B.; Boucher, E.; Ychou, M.; Pierga, J.Y.; Montot-Grillot, C.; Conroy, T.

• Book ID: 122915353
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 67 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71179-6